Companies: 10,795·Total market cap: $144.5T

Compugen Ltd.

Compugen Ltd.

CGENNASDAQHealthcare● Active

$2.04

$-0.06(-2.86%)

Market Cap$192888528

P/E Ratio—

52W High$3.24

52W Low$1.3

Avg Volume470K

Open$2.12

Beta2.74

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Compugen Ltd.（CGEN）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CGEN · 截至 Jun 8, 2026

关键指标

EPS (TTM)$0.37Earnings history

PE Ratio (TTM)5.6×PE Ratio deep dive

Revenue (TTM)$72.7MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding93.4MShares outstanding history

Next EarningsAug 5, 2026Est.Earnings history

探索 Compugen Ltd. 数据

分析师预测$5 · Buy

股息不分红

营收$72.8M+161.14%

盈利EPS $0.38+337.50%

财务快照

FY 2025Revenue$72.8M▲ +161.14% YoY

202320242025

FY 2025Net Income$35.3M▲ +348.35% YoY

202320242025

FY 2025EPS$0.38▲ +337.50% YoY

202320242025

TTM:Revenue: $72.7MNet Income: $34.9MEPS: $0.37View income statement →

分析师评级与目标价

Buy14 位分析师

Strong Buy

0

Buy

13

Hold

0

Sell

1

Strong Sell

0

12-Month Price Target

$4.00Low

$2.04Current

$4.50Avg Target上涨空间 120.59%

$5.00High

合计: 14 · 买入占比: 92.9%

根据过去 3 个月内 14 位华尔街分析师，CGEN 共识评级为 Buy，12 个月平均目标价 $4.50 （较现价 $2.04 上涨空间 120.59%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$2.04-2.86%$192.9M #2

Corbus Pharmaceuticals Holdings, Inc.

$7.64+0.00%$95.7M #3

Cardiff Oncology, Inc.

$1.51+0.00%$102.9M #4

$8.28+1.22%$413.0M #5

Innate Pharma S.A.

$1.76+2.92%$165.3M #6

Milestone Pharmaceuticals Inc.

$1.24+0.00%$106.1M

股票表现

1D-3.10%

1W-9.15%

1M-29.83%

3M-2.16%

YTD+33.01%

1Y+19.71%

5Y-73.43%

关于 Compugen Ltd.

CEOEran Ophir

IPO DateAug 11, 2000

Employees74

CountryIL

Websitecgen.com

Compugen Ltd. an Israeli-based company established in 1993 and headquartered in Holon, is a clinical-stage enterprise focused on the discovery, development, and commercialization of therapeutic and p…

Biotechnology HealthcareNASDAQIL

关于股票概览与关键数据

Compugen Ltd.（CGEN）是 Biotechnology 行业的 Healthcare 类公司，于 Aug 11, 2000 在 NASDAQ 上市。截至最近交易日，CGEN 股价为 $2.04，市值约为 $192.9M。过去12个月累计回报 +19.71%，年初至今回报 +33.01%。

根据 14 位华尔街分析师，Compugen Ltd. 股票共识评级为Buy，12个月平均目标价为 $4.50。2025 财年 Compugen Ltd. 营收 $72.8M，净利润 $35.3M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Compugen Ltd.（CGEN）股价为 $2.04，在 NASDAQ 上市，52周区间为 $1.30 – $3.24。

CGEN 最新股价CGEN quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议